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Abstract
Although its role to prevent secondary cardiovascular complications has been well established, how acetyl salicylic
acid (ASA, aspirin) regulates certain key molecules in the atherogenesis is still not known. Considering the role of
matrix metalloproteinase-9 (MMP-9) to destabilize the atherosclerotic plaques, the roles of the scavenger receptor
class BI (SR-BI) and ATP-binding cassette transporter A1 (ABCA1) to promote cholesterol efflux in the foam cells at
the plaques, and the role of NF-B in the overall inflammation related to the atherosclerosis, we addressed
whether these molecules are all related to a common mechanism that may be regulated by acetyl salicylic acid.
We investigated the effect of ASA to regulate the expressions and activities of these molecules in THP-1 macro-
phages. Our results showed that ASA inhibited MMP-9 mRNA expression, and caused the decrease in the MMP-9
activities from the cell culture supernatants. In addition, it inhibited the nuclear translocation of NF-B p65 subunit,
thus the activity of this inflammatory molecule. On the contrary, acetyl salicylic acid induced the expressions of
ABCA1 and SR-BI, two molecules known to reduce the progression of atherosclerosis, at both mRNA and protein
levels. It also stimulated the cholesterol efflux out of macrophages. These data suggest that acetyl salicylic acid
may alleviate symptoms of atherosclerosis by two potential mechanisms: maintaining the plaque stability via inhi-
biting activities of inflammatory molecules MMP-9 and NF-B, and increasing the cholesterol efflux through indu-
cing expressions of ABCA1 and SR-BI.
Introduction
The effects of acetyl salicylic acid (Aspirin, ASA) and
other drugs in the prevention of the secondary cardio-
vascular complications are well known. Several studies
have established guidelines for the usage of aspirin in
the secondary prophylaxis of vascular diseases [1,2]. The
potential roles of aspirin for primary prevention are less
well understood. Meta-analysis showed that aspirin
reduced the risks for both the nonfatal myocardial
infarction and the fatal coronary heart disease, but did
not significantly affect overall mortalities from all causes
[3].
Atherosclerosis is an inflammatory disease [4] and the
atherosclerotic plaques are formed by the accumulation
of lipid-rich macrophages (or foam cells), cholesterols
and components in the extracellular matrix (ECM). Pla-
que ruptures of thrombosis in the atherosclerosis are
the major causes of deaths in the acute coronary syn-
dromes and strokes [5]. The ruptures occur frequently
in plaques containing soft, lipid-rich cores covered by
thin and inflammatory caps of fibrous tissues [6].
There are evidences that components in the inflam-
matory pathway, including cyclooxygenase-2 (COX-2)
[7] and its product prostaglandin E2 (PGE2), contribute
to the instability of atherosclerotic plaques. MMP-9 is
also related to this pathway since its expression is regu-
lated by PGE2 in T lymphocytes and macrophage [8]. It
will be also interesting to know whether other inflam-
matory mediators such as NF-Bp l a ya n yr o l e si nt h e
mechanisms of atherosclerosis. In this regard, aspirin
exert its function mainly by suppressing the vascular
inflammation and stabilizing early atherosclerotic
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any medium, provided the original work is properly cited.plaques [9], as showed earlier from the study by Cyrus’s
group. Further studies from the same group showed
that ASA reduced the progression of atherosclerosis,
and decreased the contents of cholesterols foam cells
[10]. Since SR-BI and ABCA1 are the most important
protein members determining the contents of foam
cells, they may also be the targets of ASA.
Considering the potential connections among MMP-9,
SR-BI, ABCA1 and NF-B in related to inflammation
and atherosclerosis, and the regulatory roles played by
ASA in these mechanisms, we investigated the effects of
ASA on the expressions of these molecules using highly
relevant human macrophages.
Materials and methods
Materials
Phorbol ester (PMA) and acetyl salicylic acid (ASA)
were obtained from Caymar (Ann Arbor, MI, USA). Tri-
pure Isolation Reagents were purchased from Roche
(German), and PCR primers were synthesized by Sagon,
Shanghai. AMV Reverse Transcriptase was from Pro-
mega (Promega, Madison, USA). Scavenging Receptor
BI antibody (AB396) was obtained from Cambridge
Science Park (Cambridge, CB4 0FW, UK). ATP-binding
cassette (ABC) transporter A1 antibody was purchased
from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
THP-1 cells were from the China cell bank (Shanghai,
China). RPMI 1640 culture medium was from Hyclone
company (USA), [H
3]-Cholesterol was obtained from
GE Healthcare UK limited (Amersham Place Little Chal-
font, Bucking ghamshire HP79AN UK), and the fetal
bovine serum (FBS) was from Haily Biotechnology
(Chengdu, China).
Cell culture
THP-1 monocytes were cultured in RPMI 1640 culture
medium with 10% fetal bovine serum (FBS). After
induced by 200 nmol/L phorbol ester (PMA) for 36
hours, they differentiated into macrophages and were
then maintained in RPMI 1640 medium supplemented
with 5% FBS in the tissue culture incubator under 5%
CO2 at 37°C. Cells were grown to 60-80% of the full
volume of the culture flasks and then diluted with media
and transferred into multiple flasks for further expansion.
MTT assay
MTT assays were used to evaluate cell viabilities under
different treatments. THP-1 macrophages in the 24-
wells (Costar USA. www.scienceproducts.corning.com)
culture dish were treated in 1.2 ml media with acetyl
salicylic acid at different concentrations (300, 600, 1200
μM), then 20 μl of 3-(4, 5-dimethyl-thiazol-2-y)-2.5-
diphenyl-tetrazolium bromide (MTT, 5 mg/ml in PBS)
was added to each well. After 4 hours at 37°C, the
medium was aspirated, and the formazan crystals were
then dissolved by addition of 1 ml of 100 g/L SDS.
Reacted media from wells were read on an ELISA plate
reader at 492 nm. Since the absorbencies at 492 nm are
directly proportional to the cell viabilities, so cell viabil-
ities can be expressed as percentages of absorbencies of
test cells to that of the control.
Total RNA extraction and reverse transcription-
polymerase chain reaction (RT-PCR)
Total RNAs were isolated from the control or aspirin-
treated cells by the Tripure reagents (Roche, German).
Total RNAs of 1 μg was reverse-transcribed to cDNAs
in the RT reaction according to the manufacturer’sp r o -
tocol. Briefly, each RT reaction was performed in 50 μl
of the reaction mix containing 5 μl of 5 × reverse tran-
scriptase buffer with 50 mM MgCl2,1μlo f1 0m M
dNTP mixture, 30 U/μl RNA inhibitor, 1 μl random pri-
mers, 1 μg/μl total RNA sample. 2 μlo ft h ec D N A s
were then used for PCR amplifications. After pre-dena-
turation at 94°C for 10 min, the PCR reactions were car-
ried out by 35 cycles of 94°C for 45 s, annealing at 58°C
for 45 s, extension at 72°C for 45 s, followed by the final
single step extension at 72°C for 10 min. The RNA of
the b-actin gene was used in all reactions as internal
controls for the efficiencies of the cDNA synthesis and
the PCR amplification. The primer sequences used for
MMP-9 were 5’-CTACCACCTCGAACTTTGACAGC-
3’,a n d5 ’-CTTCCCATCCTTGAACAAATACAG-3’.
The size of the PCR MMP-9 product was 494 bp. The
primer sequences for the ABCA1 PCR were 5’-
CCCCTGTTTCCGTTACCC-3’ and 5’-AGCCCTCAG-
CATCTTGTC-3’,a n dt h es i z eo ft h eA B C A 1P C Rp r o -
duct was 289 bp. The primer sequences for SR-BI were
5’-CTGT-GGGTGAGATCATGTGG-3’ and 5’-GCCA-
GAAGTCAACCTTGCTC-3’, and PCR product size was
216 bp. Amplified cDNA products were applied on 1.5%
agarose gels, stained with Ethidium bromide and visua-
lized under a UV light.
Western blot analysis
THP-1 macrophages were grown in RPMI 1640 medium
containing 10% fetal bovine serum and incubated with
different concentrations of acetyl salicylic acid for 24 h.
The cells were washed twice with phosphate-buffered
saline and lysed in the protein extraction buffer (50 mM
Tris-Cl, 150 mM NaCl, 1% Triton-100 with 1 mM
EGTA, 2 mM EDTA and the protease inhibitors PMSF
1 mM and Atropine 5 μg/μl, and 0.1% b-ME). Total
protein concentrations were determined with the Low-
ery method, and 30 μg total proteins were separated by
7.5% SDS-PAGE and blotted onto the nitrocellulose
membrane. Blots were then incubated in 3% non-fat dry
milk in PBS with 0.1% Tween-20 for 2 h to block the
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i n c u b a t e df o ro v e r n i g h ta t4 ° C ,f o l l o w e db y2hi n c u b a -
tion with the respective secondary antibodies, and the
specific protein bands were detected by the DAB detec-
tion. The first antibodies used were a polyclonal goat-
anti-ABCA1, a polyclonal rabbit-anti-SR-BI, and a
monoclonal mouse-anti-actin, respectively for each
protein.
MMP-9 activity assay by the gelatin zymography
The culture supernatants from cells treated with differ-
ent concentrations of acetyl salicylic acid were mixed
with 5 × PAGE loading buffer (0.5 M Tris-HCl, pH 6.8;
10% SDS, 50% glycerol and 0.5% bromophenol blue).
Samples were separated in a 10% SDS-PAGE gel
embedded with 5% gelatin. The gels were washed for 30
min at room temperature in a solution containing 2.5%
(v/v) Triton X-100 and subsequently incubated with a
reaction buffer (50 mM Tris-HCL, pH 7.5; 150 mM
NaCl, 10 mM CaCl2 and 0.5 mM ZnCl2)a t3 7 ° Co v e r -
night. They were then stained for 20 min with 0.5%
Coomassie brilliant blue and destained in the solution
(40% distilled water, 10% acetic acid and 50% methanol)
for 30 min to visualize the “clear” bands where gelatin
was degraded by MMP-9 from the samples.
Cholesterol efflux assay
HDL-mediated cholesterol efflux from THP-1 foam cells
was measured as previously described [11]. THP-1
macrophages were incubated with RPMI 1640 medium
containing 10% fetal bovine serum and 0.2 μCi/mL [H
3]-
cholesterol for 24 h, then became foam cells with loaded
radioactive-labeled cholesterols. Various concentrations
of acetyl salicylic acid (0-1200 μmol/L) were added into
the fat-loaded foam cells and they were harvested 24 h
later. For the equilibration of the intracellular free choles-
terols, cells were washed with serum free medium, and
then incubated for another 24 h with RPMI 1640 med-
ium supplemented with 0.2% BSA. For free cholesterol
efflux, cells were then incubated in serum-free medium
without BSA with 50 mg/L (HDL) for up to 12 h. Then
the media were collected and centrifuged before counting
radioactivity. The cell monolayers were washed with PBS
and lysed with water. The radioactivities from the media
and the cell lysates were measured by a liquid scintilla-
tion counter. The cholesterol efflux was expressed by the
H
3-cholesterol radioactivity in the medium as the percen-
tage of the total radioactivity from both cells and the
media. Individual efflux values were averaged from three
measurements in different wells.
Densitometry and statistics
Quantifications for the relative levels of ABCA1, SR-BI,
MMP-9 mRNA and protein expressions were obtained
by the Quality One program. Statistical significance of
the data was evaluated by Student’s t test. Probability
values p < 0.05 were considered significant.
Results
To investigate whether acetyl salicylic acid affects the
expression and activation of MMP-9, we first confirmed
that ASA was not toxic to THP-1 monocytes/macro-
phages since it did not affect the cell viabilities within
the range of concentrations tested (Figure 1).
When the control or drug-treated cells were harvested
and their mRNA levels for MMP-9 were analyzed by
RT-PCR, we observed that acetyl salicylic acid inhibited
MMP-9 mRNA expression in a dose-dependent manner
(Figure 2). The efficiencies of the cDNA synthesis and
the PCR amplification were examined by the amplifica-
tion of b-actin gene fragment. We detected single bands
Figure 1 Cell viability in the presence of acetyl salicylic acid.
Cell viabilities treated by different concentrations of ASA (A) or at
different time points (B) with 600 μM ASA were determined by the
MTT assays as described in Methods and Materials. Results are
represented as mean±S.D from at least three experiments with
duplicated samples. No changes of cell viability at different time
points and concentrations of ASA.
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for b-actin mRNAs in all RT-PCR reactions.
MMP-9 is an enzyme catalyzing the cleavage of cell
extracellular matrix protein gelatin. We then investi-
gated the activities of MMP-9 secreted into the culture
media by the gelatin zymography. Consistent with the
mRNA expression data, our results showed that acetyl
salicylic acid also decreased the activities of MMP-9
secreted in the media from the treated cells both time-
dependently (Figures 3) and dose-dependently (Figure 4).
The activities of MMP-9 were reduced by 72% and 56%
at 48 h and 72 h respectively (Figure 3B), and by
6 5 %a n d4 7 %a t6 0 0μM and 1200 μM respectively
(Figure 4B).
There was report that NF-B may be involved in the
atherosclerotic inflammation [12] In order to find out
whether NF-B is of the possibility that NF-Bi s
involved ASA decreasing MMP-9 activity or not, we also
observed that ASA inhibited the NF-B subunit p65
translocation from cytoplasm to the nucleus (Figure 5),
thus inhibiting the activity of the inflammatory molecule
that requires nuclear translocation for its functions. But
molecular mechanism needs to study further.
By RT-PCR, we also examinedt h er e g u l a t i o n so fS R -
BI and ABCA1 by ASA in these same cells under similar
treatment conditions. The untreated THP-1 macro-
phages expressed low amount of basal levels of mRNAs
for both SR-BI and ABCA1 (Figure 6). Treatments with
600 μM or 1200 μM acetyl salicylic acid led to the dose-
dependent increases of SR-BI, ABCA1 mRNAs. Quanti-
fication of RT-PCR data revealed that SR-BI expression
increased by up to 1.74 and 1.83 fold at ASA 600 μM
and 1200 μM respectively (Figure 6C), and ABCA1
expression increased by up to 1.68 and 1.83 fold at ASA
600 μM and 1200 μM respectively (Figure 6D).
Western blotting analysis from total lysates revealed
1.8 and 2 fold up-regulation of SR-BI protein by ASA
600 μMa n d1 2 0 0μM respectively(Figure 7D), and ASA
increases by up to 2.1 and 2.3 fold in ABCA1 protein at
Figure 2 ASA inhibition of MMP-9 expressions in THP-1
derived macrophages. Macrophages were cultured in medium
containing 10% FBS and different concentrations of ASA for 24 h.
Total RNAs were isolated and mRNA levels for MMP-9 and Actin
genes were examined by RT-PCR analysis. Amplified cDNA products
were applied to 1.5% agarose gels, stained with ethidium bromide
and visualized under a UV light (A). The signal intensities from gels
were qualified by the Quantity One software and transformed to
the bar graph (B). Results are expressed as mean ±S.D, of three
experiments with duplicated samples. * P < 0.05,compared to
control.
Figure 3 Time-dependence of the ASA inhibition of MMP-9
activities released to media from THP-1 macrophages. The
THP-1 macrophages were cultured in media containing 10% FBS
with ASA at 600 uM for 24 h, 48 h and 72 h, and the activities of
MMP-9 were measured by gelatin Zymography (A). Signal intensities
from the zymographs were analysed by the Quantity One software
and transformed to the bar graph (B).Results are expressed as mean
±S.D, of three experiments with duplicated samples. * P < 0.05,
compared to control.
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THP-1 cells.
Since SR-BI and ABCA1 are also known to express in
macrophages and mediate HDL-induced cholesterol
efflux from these cells, we therefore tested the effect of
acetyl salicylic acid on SR-BI and ABCA1 gene expres-
sions in human monocyte-derived macrophages. In the
presence of 600 μM and 1200 μM of acetyl salicylic
acid, cholesterol efflux from treated cells was increased
by up to 2.0 and 2.3 fold respectively, as compared to
that from the untreated control cells (Figure 8).
Discussion
Previous studies have demonstrated the potent anti-
atherosclerotic and anti-metastasis activities in vitro and
in vivo for the COX inhibitor aspirin [13]. However, the
molecular mechanism of these actions is not clear.
Recent studies indicated that MMP-9 played an impor-
tant role in the development of atherosclerosis. Because
MMP-9 is the principal enzyme that degrades the type
IV collagen and gelatin in the extracellular matrix, it has
been proposed that MMP-9 is the key factor affecting
the atherosclerotic plaque stability [14]. Another recent
research showed that COX inhibitors retarded progres-
sions of established and advanced vascular atherosclero-
tic lesions by suppressing the formation of bioactive
lipids and foam cells, so SR-BI and ABCA1, as two
important mediators regulating the cholesterol contents
in foam cells, may also be the targets of the COX inhibi-
tor [10].
Our study first noted that ASA inhibited MMP-9 gene
expression in THP-1 derived macrophages in the dose-
dependent manner. As the important component in the
atherosclerotic plaque, macrophages with lower MMP-9
expression may also secret less MMP-9 enzymes. Our
work confirmed that the MMP-9 activities secreted to
media from these cells were also reduced by ASA,
which is consistent to the results from other researchers.
Several inflammatory mediators such as IL-1, TNF-a,
and ox-LDL have been shown to increase the expression
Figure 4 Dose effects of the ASA inhibition of MMP-9 activities
released to media from THP-1 macrophages. The THP-1
macrophages were cultured in media containing 10% FBS with
different concentrations of ASA for 24 h, and the activities of MMP-9
were measured by gelatin Zymography (A). Signal intensities from
the zymographs were analysed by the Quantity One software and
transformed to the bar graph (B). Results are expressed as mean ±S.
D, of three experiments with duplicated samples. * P < 0.05,
compared to control.
Figure 5 ASA inhibition of NF B-p65 protein nuclear
translocation. THP-1 macrophages were treated with 0, 600, 1200
μM ASA, nuclear proteins were extracted and analysed by Western
blot (A). Signal intensities in the blots were also measured by
Quantity One software and transformed to the bar graph (B). The
decrease at600, 1200 μM ASA was statistically significant ((P < 0.05).
Results are expressed as mean ±S.D, of three experiments with
duplicated samples. * P < 0.05,compared to control.
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bit all of these inflammatory factors. Studies showed
that ASA may affect the expression of MMP-9 in can-
cers through the inhibition of the nuclear localizations
of the AP-1 and NF-B factors [7,18]. Our study showed
that the translocation of the NF-Bs u b u n i tp 6 5w a s
inhibited by ASA at 1.2 mM and NF-B subunit p65
may be involved in the regulation of MMP-9 expression
by ASA in macrophages.
In addition, Viñals group have shown that Aspirin
produces an increase of CD36, ABCA1,SR-BI expres-
sions in THP-1 macrophages by a PGE(2)-dependent
mechanism [19], but we have demonstrated that the sca-
venger receptor class BI and ATP-binding cassette
transporter A1 increased in macrophage cells in
response to the ASA treatments lonely, The uptakes of
modified lipoproteins by macrophages are the early
steps leading to the atherosclerosis [20]. HDL-mediated
reverse cholesterol transport (RCT) represents the coun-
teracting process that may slow down the progression of
foam cell formation or even induce the regression of the
atherosclerosis lesions [21]. Reverse cholesterol trans-
port involves mainly two membrane proteins: the sca-
venger receptor class B, type I (SR-BI) that promotes a
bidirectional cholesterol movement by facilitating diffu-
sion via its interaction with mature HDL particles [22],
and the ATP-binding cassette transporter A1 (ABCA1)
that promotes phospholipids and consequent cholesterol
Figure 6 Increases of ABCA1 and SR-BI transcripts by ASA in THP-1 derived macrophages. THP-1 cells were cultured in media containing
10% FBS with different concentrations of ASA for 24 h. Total RNAs were isolated and mRNA levels for ABCA (A), SR-BI (B) with Actin as internal
controls were examined by RT-PCR analysis. Amplified cDNA products were applied to 1.5% agarose gels, stained with ethidium bromide and
visualized under a UV light (A, B). The signal intensities from gels were qualified by the Quantity One software and transformed to the bar
graphs (C, D). Results are expressed as mean ±S.D, of three experiments with duplicated samples. * P < 0.05,compared to control(Figure 6C,D).
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pre-HDL [23]. The integrities of both pre-HDL and the
mature HDL are required for the proper functions of
HDL. We found that ASA increased the expression of
SR-BI and ABCA1, so reducing the cholesterol levels in
foam cells and potentially slowing down the progression
of atherosclerosis, which is in agreement with the obser-
vations made by Cyrus T in the low LDL receptor-defi-
cient mice [10].
Together, our data demonstrated the important roles
acetyl salicylic acid plays in the regulations of a series of
key molecules involving in different aspects of inflam-
mation and atherosclerosis. It is tempting to speculate
that acetyl salicylic acid may alleviate symptoms of
atherosclerosis by two potential mechanisms: maintain-
ing the plaque stability via inhibiting activities of inflam-
matory molecules MMP-9 and NF B, and increasing
the cholesterol efflux through inducing expressions of
ABCA1 and SR-BI.
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